Aim: The syndrome of thyroid hormone resistance (RTH) is characterised
by elevated circulating thyroid hormones, unsuppressed TSH levels and
peripheral refractoriness to hormone action. Patients with RTH may be
clinically hyperthyroid if the pituitary gland is more insensitive th
an other tissues to thyroid hormones. More often. patients have periph
eral tissue resistance as well and are euthyroid. RTH is related to po
int mutations in the TS-binding domain of the beta-receptor gene. We r
eport the variable clinical and biochemical features of five patients
with RTH. Methods: Five patients with RTH were clinically and biochemi
cally evaluated: thyroid tests were done at baseline, after TRH stimul
ation and after T3-suppression test. Thyroid ultrasound was performed
as well. Individual exons of the thyroid hormone receptor beta gene we
re amplified from leucocyte DNA in these patients using the polymerase
chain reaction (PCR). Results: Sequence analysis identified a single
point mutation at a certain nucleotide position. This corresponds to a
minoacids substitutions at one position in the predicted aminoacid seq
uence. RTH was familiar in three individuals and sporadic in two. Thre
e of the patients underwent thyroid surgery or radioiodine treatment b
ecause of recurrent goiter and/or ''refractory hyperthyroidism''. More
over, one of our patients with RTH developed also hyperthyroidism due
to Graves' disease and underwent thyroid surgery for the third time. H
er brother, besides RTH. demonstrated strongly positive TPO-antibodies
and a hypoechogenic pattern on ultrasound. So the diagnosis of Hashim
oto's thyroiditis was made. Conclusions: RTH has to be considered in a
ll patients with inappropriate TSH secretion. The clinical manifestati
on of patients with RTH is heterogenous. Thyroid antibody measurements
should be performed regularly in order to detect the development of c
oexisting autoimmune thyroid disease.